| Serial Number | 97334920 |
| Word Mark | M-GAGER |
| Filing Date | Monday, March 28, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, October 10, 2023 |
| Registration Number | 7186176 |
| Registration Date | Tuesday, October 10, 2023 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 25, 2023 |
| Goods and Services | Biochemical preparations for medical use, namely for use in the treatment of cancer; Biological preparations for medical purposes, namely for use in the treatment of cancer; biotechnological products for medical use, namely medical preparations for the treatment of cancer; Pharmaceuticals for use in the treatment of cancer; Pharmaceutical preparations for use in the treatment of cancer; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of autoimmune diseases; Anti-inflammatory preparations; Immunostimulants; Medicines for human purposes namely, medicinal preparations for the treatment of cancer; Medicines for veterinary purposes namely, veterinary pharmaceutical preparations for the treatment of cancer; Chemico-pharmaceutical preparations namely, chemical preparations for pharmaceutical or medical purposes, namely for use in the treatment of cancer; Diagnostic agents for medical use; Pharmaceuticals, medical and veterinary preparations, namely pharmaceutical preparations for use in the treatment of cancer |
| Goods and Services | Scientific and medical research and development in the field of cancer; Biological and chemical research; Research relating to biotechnology; Pharmaceutical research and development; Research and development services in the field of immunology; Laboratory analysis in the field of molecular biology; Provision of information relating to medical and veterinary research and development in the field of cancer; Consultancy in the field of pharmaceutical research; Consultancy relating to research and development in the field of therapeutics; consultancy relating to biotechnology; Scientific laboratory services; Analytical laboratory services, namely, laboratory analysis in the field of cancer; Services of a chemical or biological laboratory, namely, chemical and biological research and analysis; Research and development services for the pharmaceutical industry; Product development; Quality control for others; Research and development services in the field of antibodies; Scientific research services in the field of proteins, antibodies, microorganisms and cells; Scientific and technological services, namely, scientific analysis and research services in the field of cancer; Chemical analysis; Medical and scientific research, namely, conducting clinical trials for others; Providing of information relating to medical and scientific research on pharmaceutical products |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, May 22, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, May 22, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | CDR-Life AG |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Horgen 8810 CH |
| Party Name | CDR-Life AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Schlieren-Zurich CH-8952 CH |
| Party Name | CDR-Life AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Schlieren-Zurich CH-8952 CH |
| Event Date | Event Description |
| Thursday, December 7, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, December 7, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, December 7, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, December 7, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Thursday, December 7, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, October 10, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, October 10, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, July 25, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 25, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, July 5, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, May 22, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, May 22, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Monday, May 22, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, May 22, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Monday, May 22, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, April 24, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, April 24, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, April 24, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, January 23, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, January 23, 2023 | NON-FINAL ACTION E-MAILED |
| Monday, January 23, 2023 | NON-FINAL ACTION WRITTEN |
| Wednesday, January 11, 2023 | ASSIGNED TO EXAMINER |
| Monday, May 23, 2022 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
| Sunday, May 22, 2022 | ASSIGNED TO LIE |
| Tuesday, May 17, 2022 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Friday, April 1, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, March 31, 2022 | NEW APPLICATION ENTERED |